Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Allergan pushes on with Botox for depression

Allergan pushes on with Botox for depression The specialty pharma group took the decision to test Botox in depression after external research groups showed evidence of efficacy in MDD in two separate early-stage trials. ... But analyst Ronny Gal of Bernstein thinks that if the gamble pays off, a

Allergan adds Zeltiq to M&A roster in $2.48n deal

Allergan adds Zeltiq to M&A roster in $2.48n deal Saunders said the deal gives its aesthetic pharmaceuticals business another pillar alongside Botox for facial wrinkles, its plastic surgery products and regenerative medicines. ... The division grew 40% to $1.62bn last year, with the sales increase

Allergan buys regenerative medicine firm LifeCell for $2.9bn

Allergan buys regenerative medicine firm LifeCell for $2.9bn Those are headed by blockbuster wrinkle treatment Botox but also include Kybella - bought along with Kythera last year for $2.1bn - for reducing double chins and dermal filler Juvederm.

Shire launches dry eye drug Xiidra in US

Shire launches dry eye drug Xiidra in US Allergan made around $1.3bn in sales from Restasis last year, which made it the company's second-biggest product after wrinkle treatment Botox.

Explosive evolution

Explosive evolution governments. We see this when we compare, for example, generic Paracetamol with Allergan's Botox and Bayer's Xarelto.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics